Lung cancer screening
The Nelson study has shown that low dose CT screening can be an effective way of reducing lung cancer mortality. Developing a lung cancer screening program requires in-depth knowledge on various questions. iDNA assists decisionmakers with setting up a (pilot) lung cancer screening program, by answering questions on:
- Recruitment of participants
- Population-based tailored interventions
- Screening protocol (measurements of nodules, screening intervals)
- Data management and quality control
- Cost-benefit of implementation (QALYS and costs)
- System (phantom) calibration and image reading
- Comorbidities in cardiovascular diseases and COPD
- Biomarker development and metabolic profiling
- Treatment follow-up
iDNA has the ambition to help the world reduce lung cancer related mortality through high quality screening programs. We can create an implementation plan according to your needs, and build a business case for decision makers. Our strategic partner for health effectiveness models is ASC Academics (https://www.ascacademics.com/), a global market access and health economics consultancy.
iDNA: the Institute for Diagnostic Accuracy. iDNA was launched by members of the NELSON group and is backed by numerous scientific experts and business leaders. We are established in the Netherlands, where the NELSON protocol was developed. Our mission is to reduce the burden of lung cancer by assisting health care organizations and governments in successfully and effectively implementing the NELSON protocol.
We would be honoured to support you in setting up a lung cancer screening programme in your country, region or hospital. Please enter your request on the right, or send a direct email to info@i-DNA.org if you have any questions.